The present invention relates to compositions and methods relating to the
characterization and function of CYT28. Specifically, the present
invention provides transgenic animals comprising disruptions in a CYT28
gene and methods of treating diseases conditions, such as pain. The
present invention further relates to agents that modulate CYT28 and
methods of screening for agents that modulate CYT28 for the treatment of
diseases and conditions such as pain.